Daily Ards Research Analysis
Three ARDS studies stood out today: a systematic review from Sub-Saharan Africa exposes large diagnostic and resource gaps with high, variable mortality; a prospective cohort shows driving pressure, not mechanical power, independently predicts mortality; and a multicenter neonatal cohort identifies gestational-age–dependent interactions with high-frequency ventilation and inhaled nitric oxide that increase mortality risk.
Summary
Three ARDS studies stood out today: a systematic review from Sub-Saharan Africa exposes large diagnostic and resource gaps with high, variable mortality; a prospective cohort shows driving pressure, not mechanical power, independently predicts mortality; and a multicenter neonatal cohort identifies gestational-age–dependent interactions with high-frequency ventilation and inhaled nitric oxide that increase mortality risk.
Research Themes
- Resource-limited ARDS care and diagnostic adaptation
- Ventilator physiology and prognostication in ARDS
- Neonatal ARDS risk stratification and treatment interactions
Selected Articles
1. Epidemiology, management and outcome of acute respiratory distress syndrome in Sub-Saharan Africa: a systematic review.
This systematic review across 11 Sub-Saharan African countries found highly variable ARDS prevalence, frequent use of the Kigali modification due to limited diagnostics, constrained access to invasive ventilation, and mortality ranging from 22% to 77%. The dominant etiologies were pneumonia, sepsis, and trauma, with substantial contributions from HIV, TB, and malaria.
Impact: It provides the first consolidated view of ARDS burden, diagnostics, and management gaps in SSA, guiding context-appropriate policies and capacity building.
Clinical Implications: Adopt context-adapted diagnostic criteria (e.g., Kigali modification), expand access to oxygen therapy and invasive ventilation, and prioritize critical care training and infrastructure to reduce mortality.
Key Findings
- ARDS prevalence across SSA ranged from 2.4% to 100% among included studies.
- The Kigali modification of the Berlin criteria was most commonly used due to limited chest radiography and arterial blood gases.
- Pneumonia, sepsis, and trauma were predominant causes; HIV, tuberculosis, and malaria contributed substantially.
- Access to invasive mechanical ventilation was limited; mortality ranged from 22% to 77%.
Methodological Strengths
- Systematic review across 11 countries with explicit focus on resource-limited settings
- Contemporary timeframe (2000–2024) capturing evolving ARDS definitions and practices
Limitations
- High heterogeneity in definitions, diagnostics, and reporting across studies
- Limited number of studies and potential publication bias reduce generalizability
Future Directions: Establish prospective multicenter registries in SSA, validate context-adapted diagnostic criteria, and test scalable interventions (oxygen systems, training, ventilation protocols) to reduce mortality.
OBJECTIVES: To evaluate the incidence, management, and outcomes of Acute Respiratory Distress Syndrome (ARDS) in Sub-Saharan Africa (SSA), and to identify challenges related to healthcare infrastructure and resource availability. DESIGN: Systematic review of published studies on ARDS in SSA. SETTING: Studies conducted across hospitals and intensive care units in 11 countries within Sub-Saharan Africa between 2000 and 2024. PARTICIPANTS: Adult patients diagnosed with ARDS. MAIN OUTCOME MEASURES: Prevalence of ARDS, patient demographics, management strategies, availability of critical care resources, and mortality rates. RESULTS: Thirteen studies met the inclusion criteria. ARDS prevalence varied widely, ranging from 2.4% to 100%. The Kigali modification of the Berlin criteria was most frequently applied, reflecting limited access to chest radiography and arterial blood gas analysis. Pneumonia, sepsis, and trauma were the predominant causes, with infectious diseases such as HIV, tuberculosis, and malaria contributing substantially. Access to invasive mechanical ventilation and other critical care resources was limited. Reported mortality rates ranged from 22% to 77%. CONCLUSIONS: ARDS represents a major but under-recognised cause of morbidity and mortality in SSA. Resource limitations, including inadequate diagnostic capacity and restricted access to mechanical ventilation, likely contribute to poor outcomes. Efforts to strengthen critical care infrastructure, provide targeted training, and adapt diagnostic criteria for low-resource environments are urgently needed. Further research should explore regional variations and context-appropriate interventions to improve ARDS care across SSA.
2. Mechanical Power and its Components vs Driving Pressure for Predicting Mortality in Acute Respiratory Distress Syndrome: A Prospective Observational Study.
In 137 ARDS patients, mechanical power was higher among non-survivors but lost independent association with mortality after adjustment, whereas driving pressure remained an independent predictor. Elastic dynamic power contributed most to elevated mechanical power.
Impact: It clarifies conflicting evidence by demonstrating that driving pressure, not mechanical power, independently predicts mortality in ARDS, directly informing ventilator management.
Clinical Implications: Prioritize minimizing driving pressure during lung-protective ventilation; use mechanical power and its components as contextual metrics rather than primary prognostic targets.
Key Findings
- Among 137 ARDS patients, 53.3% were non-survivors.
- Median mechanical power was higher in non-survivors (29 J/min) vs survivors (24 J/min).
- After adjustment, mechanical power was not an independent predictor of mortality; driving pressure was.
- Elastic dynamic power was the dominant component contributing to high mechanical power.
Methodological Strengths
- Prospective observational design with predefined physiologic variables
- Multivariable adjustment assessing MP, its components, and driving pressure alongside clinical factors
Limitations
- Single-center study limits generalizability
- Moderate sample size; no interventional comparison or external validation
Future Directions: Conduct multicenter studies to validate driving pressure thresholds and integrate DP into ventilator management protocols and decision-support tools.
AIM: Mechanical power (MP) has been proposed as a predictor of acute respiratory distress syndrome (ARDS) mortality, but evidence remains conflicting. We aimed to study its prognostic utility in predicting mortality in ARDS. PATIENTS AND METHODS: This was a single-center prospective observational study including 137 ARDS patients. The organ dysfunction scores, MP and its components (elastic static, elastic dynamic, and resistive power), driving pressure (DP), severity of acute kidney injury (AKI), lung ultrasound scores, pulmonary artery hypertension, days of intensive care unit (ICU) stay, and mortality outcomes were noted. RESULTS: Out of 137 ARDS patients, there were 73 (53.3%) non-survivors. Mechanical power was significantly higher with median [interquartile range (IQR)] 29 (24.55-32) J/min in the mortality group and 24 (20-28.75) J/min in the survival group ( CONCLUSION: Although MP is significantly higher in ARDS non-survivors as compared to survivors, adjustments for confounders showed that it is not an independent predictor of mortality. Driving pressure is an independent predictor of mortality. Elastic dynamic power is the most important component of high MP. HOW TO CITE THIS ARTICLE: Medhi PP, Chaudhuri S, Parampalli V, Devadiga S, Mareguddi AB, Karanth S,
3. Risk factors for mortality in neonatal ARDS: a multicenter retrospective cohort study in China.
In a multicenter retrospective cohort of neonates with ARDS requiring IMV within 72 hours of birth, LASSO-selected variables (iNO, HFV, GA, IMV duration) were associated with mortality. Higher gestational age, receipt of iNO, and HFV were linked to increased mortality; GA ≥38.785 weeks and IMV duration <117 hours marked higher risk, with significant interactions between iNO–IMV and HFV–GA.
Impact: It challenges assumptions that greater gestational maturity confers protection by identifying a GA-dependent risk increase when HFV and iNO are used, refining neonatal ARDS risk stratification.
Clinical Implications: When considering HFV and iNO in neonates with higher GA, clinicians should recognize potential increased mortality risk, intensify monitoring, and weigh alternative strategies while validating in prospective studies.
Key Findings
- Four variables (iNO, HFV, GA, IMV duration) were identified by LASSO and associated with mortality in Cox models.
- Higher GA, receiving iNO, and undergoing HFV were associated with higher mortality on Kaplan–Meier analysis.
- Restricted cubic spline indicated GA ≥38.785 weeks and IMV duration <117 hours corresponded to significantly increased mortality risk.
- Significant interactions were observed between iNO and IMV duration, and between HFV and GA.
Methodological Strengths
- Multicenter cohort with modern variable selection (LASSO) and Cox modeling
- Use of restricted cubic splines and interaction analysis to characterize nonlinear and effect-modifying relationships
Limitations
- Retrospective design with potential confounding by indication for HFV and iNO
- Sample size and external generalizability not specified in the abstract; potential center-level practice variability
Future Directions: Prospective validation and randomized or pragmatic trials to test HFV and iNO strategies stratified by gestational age and IMV duration thresholds.
As a life-threatening respiratory syndrome, epidemiological data from China has shown that the mortality rate of neonatal acute respiratory distress syndrome (ARDS) is as high as 12.5%. Nevertheless, studies on the influencing factors of this mortality remain limited. This research enrolled newborns with ARDS who initiated invasive mechanical ventilation (IMV) within 72 hours after birth. A Cox regression model with hazard ratio (HR) was constructed using the least absolute shrinkage and selection operator analysis with the lambda.1se screening criterion. Four characteristic variables were identified: inhaled nitric oxide (iNO), high frequency ventilation (HFV), gestational age (GA), and IMV duration. The Kaplan-Meier curve indicated that infants with a higher GA, receiving iNO, or undergoing HFV had a higher risk of death. Restricted cubic spline analysis further revealed that GA ⩾ 38.785 weeks and IMV duration < 117 hours were associated with a significant mortality risk. A linear trend test confirmed a significant linear relationship between GA and mortality risk. Significant interaction effects were observed between "iNO" and "IMV" as well as between "HFV" and "GA". This study underscores that neonates with advanced GA who require concomitant HFV and iNO therapy are associated with a significantly heightened mortality risk.